New COVID booster for teens shows promise in trial
NCT ID NCT06234956
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study tested whether BIMERVAX, a COVID-19 booster shot, is safe and works well in teenagers aged 12 to 17. About 242 teens who had already received a different COVID vaccine got one dose of BIMERVAX. Researchers measured their immune response and tracked any side effects for up to a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAP Centelles
Centelles, Barcelona, 08540, Spain
-
CAP Peralada
Peralada, Girona, 17491, Spain
-
Hospital HM Montepríncipe
Boadilla del Monte, Madrid, 28660, Spain
-
Hospital HM Puerta del Sur
Móstoles, Madrid, 28938, Spain
-
Hospital Josep Trueta
Girona, Girona, 17007, Spain
-
Hospital La Paz
Madrid, Madrid, 28046, Spain
-
Hospital Vall Hebron
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.